Mandatory use of prescription drug monitoring programs

JAMA - Journal of the American Medical Association

Volumn 313, Issue 9, 2015, Pages 891-892

  Haffajee, Rebecca L ^a   Jena, Anupam B ^a,b,c   Weiner, Scott G ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; DRUG ABUSE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH CARE POLICY; HUMAN; LEGAL LIABILITY; MANDATORY PROGRAM; MEDICAL HISTORY; MEDICAL PRACTICE; MEDICAL RECORD; NOTE; PRESCRIPTION; PRIORITY JOURNAL; SELECTION BIAS; DRUG CONTROL; DRUG UTILIZATION; LEGISLATION AND JURISPRUDENCE; UNITED STATES; UTILIZATION;

PRESCRIPTION DRUG;

DRUG AND NARCOTIC CONTROL; DRUG UTILIZATION; HUMANS; MANDATORY PROGRAMS; PRESCRIPTION DRUGS; UNITED STATES;

EID: 84924513729     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.18514     Document Type: Note

References (10)

1. Warner M, Hedegaard H, Chen LH. Trends in drug-poisoning deaths involving opioid analgesics and heroin. http://www.cdc.gov/nchs/data/hestat/drug-poisoning/drug-poisoning.htm. Accessed December 20, 2014.
2. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report. http://archive.samhsa.gov/data/2k13/DAWN127/sr127-DAWN-highlights.htm. Accessed December 20, 2014.
3. Kreiner P, Nikitin R, Shields TP. Bureau of Justice Assistance prescription drug monitoring program performance measures report. http://www.pdmpexcellence.org/sites/all/pdfs/BJA%20PDMP %20Performance%20Measures%20Report %20Jan%202009%20to%20June%202012 %20FInal-with%20feedback.pdf. Accessed December 20, 2014.
4. National Alliance for Model State Drug Laws. States that require prescribers and/or dispensers to access PMP database in certain circumstances. http://www.namsdl.org/library/4475CD3E-1372-636C-DD2E5186156DFB6F. Accessed December 20, 2014.
5. Prescription Drug Monitoring Program Center of Excellence at Brandeis. COE briefing. http://www.pdmpexcellence.org/sites/all/pdfs/COE-briefing -mandates-2nd-rev.pdf. Accessed December 20, 2014.
6. Commonwealth of Massachusetts Department of Public Health. Prescription monitoring program. http://www.mass.gov/eohhs/gov/laws-regs/dph/proposed-regulations/prescription-monitoring-program.html. Accessed December 20, 2014.
7. Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145C: 34-47.
8. National Alliance for Model State Drug Laws. States that require all licensed prescribers and/or dispensers to register with the state prescription drug monitoring program. http://www.namsdl.org/library/4473E1D9-1372-636C-DD9BFB83468ABBC4/. Accessed December 20, 2014.
9. Perrone J, Nelson LS. Medication reconciliation for controlled substances-An "ideal" prescription-drug monitoring program. N Engl J Med. 2012;366(25): 2341-2343.
10. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results from the 2013 National Survey on Drug Use and Health. http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. Accessed December 20, 2014.